1st Quarter - Report
CRISPR THERAPEUTICS, INC. for CRISPR THERAPEUTICS, INC.
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Coverage & reimbursement for Cell and Gene Therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN | — |
Health Issues HCR
Coverage & reimbursement for Cell and Gene Therapies Sickle Cell Disease
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN | — |
Medicare/Medicaid MMM
Reimbursement for cell and gene therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN | Head of Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.